News | Magnetic Resonance Imaging (MRI) | July 24, 2025

Following the recent FDA clearance of the new Swoop System, two leading hospitals in the U.S. have purchased the first commercial units, marking the launch of next-generation portable MR brain imaging.

Hyperfine Announces the First Commercial Sales of the Next-Gen Portable MRI  System

July 17, 2025 – Hyperfine, Inc.recently announced the first commercial sales of the next-generation Swoop system.The Swoop system is the first FDA-cleared AI-powered portable MRI system for the brain. The Swoop system is powered by proprietary Optive AI software.

Two pioneering hospitals in the northeast U.S. plan to utilize the technology in their intensive care units and emergency department settings.

The initial sales of the next-generation Swoop system—purchased by two top-tier hospitals in the northeastern United States—demonstrate a strong market response following FDA clearance and mark a critical step toward the widespread clinical adoption of portable brain imaging with diagnostic-level clarity.

“This marks the start of a new phase for Hyperfine — one where our vision to transform MRI access is driven by a new system that is commercially ready, is clinically valuable, has outstanding image quality and functionality, and is garnering strong customer interest,” commented Maria Sainz, president and CEO of Hyperfine. “Attaining the milestone of first commercial sales and deliveries of the new Swoop system just weeks after FDA clearance is the result of seamless execution across the organization — from industry-leading product development to accelerated clearance to rapid manufacturing ramp to initial sales. We are excited about the momentum with the new Swoop system and the growth we anticipate in the second half of 2025 and beyond.”

The new Swoop system features innovations specifically engineered to deliver the highest signal-to-noise ratio, which, when paired with the Optive AI software, achieve exceptional image quality, including improved resolution, uniformity, and faster acquisition times. This new level of image quality has the potential to dramatically drive the adoption of the Swoop system across sites of care and multiple clinical applications. The new Swoop® system also delivers a user and patient-centric design to accommodate a broad patient population—especially beneficial for pediatric, elderly, or anxious patients—making MRI more accessible for all.

For more information about the Swoop Portable MR Imaging system, please visit HyperfineMRI.com.


Related Content

News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Radiology Imaging

Jan. 26, 2026 — Researchers at the University of Arizona were awarded up to $1.8 million by the Advanced Research ...

Time January 26, 2026
arrow
News | Computed Tomography (CT)

Jan. 21, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) cleared the industry's first ...

Time January 23, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
Subscribe Now